| Document |
Document Title |
|
WO/2020/137706A1 |
[Problem] The purpose of the present invention is to provide a new method for producing a cycloastragenol analog from astragaloside IV. {Solution] A method for producing a cycloastragenol analog that includes a contact step that brings a...
|
|
WO/2020/125307A1 |
Disclosed is a method for constructing a Pseudomonas aeruginosa O11 serotype O antigen oligosaccharide using a D-glucose block, a L-fucosamine block and a D-fucosamine block, wherein the D-glucose block or the L-fucosamine block is conne...
|
|
WO/2020/127194A1 |
Anticancer compounds of formula (I) and derivatives thereof are provided.
|
|
WO/2020/123877A1 |
The present invention relates to novel steviol glycosides R6-1, R6-2A, R6-2B, R6-4A, R6-4B and R7-2 and the production of these novel steviol glycosides, such as through enzymatic bioconversion. The use of these novel steviol glycosides ...
|
|
WO/2020/120474A1 |
The present invention provides certain tetrapyrrolic compounds having a structure of Formula (1), (2), or (3) wherein B is (I), (II) (III) or (IV), O-R1 is a substituent in the meta or para position of the phenyl ring, R1 is a glyco-subs...
|
|
WO/2020/115190A1 |
The present invention relates to novel aminoglycoside compounds having antimicrobial properties and being suitable, for example, as therapeutic agents for use in the treatment of mammalian disease and in particular to novel therapeutic a...
|
|
WO/2020/113926A1 |
The present invention relates to the field of modification and extraction of natural compounds. Disclosed is a method for realizing a high value for a stevioside mother liquor sugar. According to the present invention, lactase is used to...
|
|
WO/2020/114418A1 |
The present invention relates to an anticoagulant compound having an anionic form represented by formula (A), a preparation method thereof, and a use of the same in preparing a drug for preventing and/or treating a disease related to coa...
|
|
WO/2020/114287A1 |
The present invention relates to a ruthenium-nickel/activated carbon co-supported catalyst, a preparation method therefor and a use thereof in the preparation of sugar alcohols by means of sugar catalysis and hydrogenation. According to ...
|
|
WO/2020/111280A1 |
The present invention provides a nucleic acid complex represented by formula 1. Formula 1: (In formula 1, X is a double-stranded nucleic acid that comprises a sense strand and an antisense strand and that includes a duplex region of at l...
|
|
WO/2020/108149A1 |
Disclosed is a preparation method for cyclic purification of mother liquor sugar and extraction of renaudiside (RA) and stevioside (ST), comprising heating and stirring a mother liquor sugar comprising more than 70% of total glycosides w...
|
|
WO/2020/113124A1 |
Provided herein are methods of treating an ocular disease associated with one or more nonsense mutation in a subject using one or more aminoglycosides and/or derivatives thereof. The pharmaceutical compositions and kits containing one or...
|
|
WO/2020/112957A1 |
Methods of preparing highly purified steviol glycosides, particularly steviolmonoside, steviolmonoside A, steviolbioside, steviolbioside D, rubusoside, steviolbioside A, steviolbioside B, rebaudioside B, stevioside, rebaudioside G, stevi...
|
|
WO/2020/104335A1 |
The present invention relates to a compound of the general formula (1). The compound of formula (1) is suitable for use in a method for treating a disorder relating to the binding of a galectin, such as galectin-3 to a ligand in a mammal...
|
|
WO/2020/102910A1 |
Herein, we describe the development of non-β-lactam-based potentiator molecules that synergize with β-lactam antibiotics and β-lactam-β-lactamase inhibitor combinations against MDR/XDR P. aeruginosa phenotypes. The compound comprises...
|
|
WO/2020/106636A1 |
Provided are 13-membered macrolides for the treatment of infectious diseases. The 13- membered macrolides described herein are azaketolides. Also provided are methods for preparing the 13-membered macrolides, pharmaceutical compositions ...
|
|
WO/2020/072834A9 |
The invention provides compositions and methods for treating asthma in a subject in need thereof comprising administering chemically synthesized secoisolaricirecinol diglucoside (SDG), and in particular, a racemic mixture of the SDG (LGM...
|
|
WO/2020/084094A1 |
The present invention relates to a process for preparing a nitrated compound, comprising the step of reacting a compound (A) comprising at least one substituted or unsubstituted aromatic or heteroaromatic ring, wherein said heteroaromati...
|
|
WO/2020/086559A1 |
Methods of isolating dihydrochalcone compounds of Formula (I) from Balanophora harlandii are provided herein. Compositions and consumables comprising at least one sweetener and at least one dihydrochalcone compound described herein are a...
|
|
WO/2020/078807A1 |
The present invention relates to a prodrug compound of the general formula I or II. The prodrug compound of formula I or II is suitable for use in a method for treating a disorder relating to the binding of a galectin, such as galectin-3...
|
|
WO/2020/078808A1 |
The present invention relates to a compound of the general formula I or II. The compound of formula I or II is suitable for use in a method for treating a disorder relating to the binding of a galectin, such as galectin-3 to a ligand in ...
|
|
WO/2020/077970A1 |
Provided in the present invention is a highly efficient stevioside mixture preparation method, the preparation method comprising the following steps: (1) placing crude stevioside into a sealed pressure-resistant system or apparatus, and ...
|
|
WO/2020/070732A1 |
The present invention relates to a field of treatment and prevention of overweight and obesity. In particular the present invention is directed to an oral composition comprising (beta)-escin (beta-escin) for use in prevention of extracel...
|
|
WO/2020/063894A1 |
An industrialization method for comprehensive utilization of stevia rebaudiana. The major improvement is in that the stevia rebaudiana is extracted by using a high-concentration alcohol solution, then the extracted solution is purified b...
|
|
WO/2020/069091A1 |
A method of suspending elemental sulfur in water includes the steps of providing water including elemental sulfur and hydrogen sulfide and adding from about 1 to about 100 parts by weight of a sulfur suspension additive to the water base...
|
|
WO/2020/065309A1 |
The present invention provides a therapeutic combination for use in treating an infection with a pathogen. The therapeutic combination comprises an aminoglycoside antibiotic; and a nucleic acid monoalkylating agent that substitutes a sin...
|
|
WO/2020/063892A1 |
Disclosed is an industrial method for simultaneously preparing stevia rebaudiana chlorogenic acid and stevioside. The industrial method includes carrying out alcohol extraction on stevia rebaudiana which is used as a raw material, and th...
|
|
WO/2020/057605A2 |
Disclosed are a glucose compound, a pharmaceutical composition, and an application thereof. The present invention provides the glucose compound as shown in formula (I) or a pharmaceutically acceptable salt thereof, which has almost no ac...
|
|
WO/2020/058322A1 |
The present invention provides glucose sensitive insulin derivatives comprising a macrocycle, a glucose mimetic and human insulin or an analogue thereof, and their pharmaceutical use. Furthermore, the invention relates to pharmaceutical ...
|
|
WO/2020/053207A1 |
The invention relates to an improved method for producing isomalt from a carbohydrate mix containing isomaltulose and saccharose.
|
|
WO/2020/050462A1 |
The present invention relates to a naphthopyrone derivative and a composition comprising, as an active ingredient, a Cassia obtusifolia shoot extract including the naphthopyrone derivative. A composition according to an aspect of the pre...
|
|
WO/2020/050865A1 |
A method of treating a triterpene-responsive condition, disease or disorder in a subject by administration of an improved triterpene-based composition is provided. An improved triterpene-based composition comprising at least two or at le...
|
|
WO/2020/034987A1 |
Disclosed are a compound of formula I of a prodrug of a JAK inhibitor, a pharmaceutical composition thereof, a method for treating inflammatory diseases and tumors by using the compound, as well as a method and an intermediate for prepar...
|
|
WO/2020/032152A1 |
Current synthesis methods for 4'-substituted nucleoside derivatives include a step in which stereoisomers are produced and therefore have problems such as decreased yield and complication of a refinement step. Thus, a synthesis method ha...
|
|
WO/2020/018474A2 |
The present invention provides compounds isolated from avocado seeds for use as a natural colorant in edible materials. The compounds of the invention are useful for coloring edible materials red, orange, or yellow. The invention also pr...
|
|
WO/2020/014409A1 |
Provided herein are senolytic agents for selectively killing senescent cells that are associated with numerous pathologies and diseases, including age-related pathologies and diseases. As disclosed herein, senescent cell-associated disea...
|
|
WO/2020/007760A1 |
The present invention relates to novel pharmaceutically acceptable salts of TLR4 agonist compounds and forms thereof, corresponding pharmaceutical compositions or formulations, processes or methods of compound preparation and uses or tre...
|
|
WO/2020/001166A1 |
Disclosed are a glycoside compound represented by formula (III) and a preparation method therefor, a composition, an application, and an intermediate. The provided glycoside compound is simple in preparation method, can remarkably improv...
|
|
WO/2020/001516A1 |
Rebaudioside A1G, a preparation method therefor, a purification method therefor and a use thereof in food. The preparation method comprises: providing rebaudioside A and a glucose-based donor, and producing rebaudioside A1G by means of t...
|
|
WO/2020/006194A1 |
Systems and apparatuses for producing microbe-based compositions that can be used in the oil and gas industry, environmental cleanup, as well as for other applications are provided. More specifically, apparatuses comprising two vessels f...
|
|
WO/2019/243825A1 |
The present invention relates to conjugates of small molecule modulators of the Stimulator of Interferon Genes (STING) protein.
|
|
WO/2019/238965A1 |
The present invention relates to several novel 1-O-glycosylated sphingoid bases and to a production method thereof, as well as to uses of the 1-O-glycosylated sphingoid bases. Sphingoid bases carrying a vinylogous amide-type protecting g...
|
|
WO/2019/234763A1 |
The present invention discloses lincomycin sustained release tablets. More particularly, the invention discloses sustained release tablets of lincomycin 1000mg for once a day administration.
|
|
WO/2019/230863A1 |
Disclosed are: a method for manufacturing a compound (5-epi-4"-N-(L-isoceryl)apramycin) and 5-epiapramycin; and an intermediate used for said method. The method of the present invention is useful in that the compound (5-epi-4"-N-(L-isoce...
|
|
WO/2019/227228A1 |
The present disclosure relates to analogs of N-acetyl glucosamine fluorinated at 4- and/or 6-position(s) and derivatives of xylose at anomeric position for the treatment of a neurological disease, inflammation, cancer and a central nervo...
|
|
WO/2019/222269A1 |
Provided are biaryl amides and coumarin-based compounds with modified sugar groups for treatment of diseases associated with heat shock protein pathway. The compounds having the following formulas, wherein variables are as defined herein...
|
|
WO/2019/222424A1 |
Disclosed are cationic lipids which are compounds of Formula (I'). Cationic lipids provided herein can be useful for delivery and expression of mRNA and encoded protein, e.g., as a component of liposomal delivery vehicle, and accordingly...
|
|
WO/2019/222601A1 |
Methods of preparing concentrated solutions of crystalline steviol glycoside compositions having relatively high rebaudioside M content are provided herein. The concentrated solutions are stable and can be used to prepared beverage syrup...
|
|
WO/2019/196920A1 |
The present application falls within the field of medical technology, and relates to crystals of glycyrrhizic acid derivatives, crystalline compositions, pharmaceutical compositions and uses thereof, in particular relates to type A cryst...
|
|
WO/2019/194858A1 |
The present disclosure relates to novel methods for preparing antibacterial aminoglycoside compounds and the compounds used in such preparations.
|
